Plus, Simon Property Group is acquiring Taubman Centers for $3.6 billion, and Eli Lilly shares are down after a failed trial for its Alzheimer’s drug candidate.
Read MoreBuy Target – $7.25 or better Sell Target – TradersPro Sell Signal NantKwest, Inc., a clinical-stage immunotherapy company, develops immunotherapeutic treatments for cancer and viral infectious diseases in the United States. The company develops activated natural killer (aNK) cell, a natural killer cell-line and genetically modified derivative capable of killing cancer and virally infected cells; […]
Read MorePlus, Tesla shares are taking a hit as its production in China is halted by the coronavirus, private payrolls soared by 291,000 in January, and Macy’s just released a new turnaround plan.
Read MorePlus, Gilead Sciences may have an effective treatment for the rapidly-spreading virus, and manufacturing delivered an unexpected rebound.
Read MorePlus, the Chinese coronavirus has spread to more than 4,600 patients, U.S. consumer confidence grew this month, and the U.K. is allowing vendors to use Huawei hardware in the build-out of the country’s 5G network.
Read MorePlus, Johnson & Johnson’s chief scientific officer said he believes the company can develop a vaccine for the deadly virus within the next couple of months, and GM announced it’s investing $3 billion on the production of electric vehicles.
Read MoreThese could be a few of the Dow’s top performers in 2020.
Read MorePlus, Tesla began delivering Model 3s from its new Shanghai factory, and AstraZeneca and Merck’s cancer drug just got approved to treat pancreatic cancer.
Read MorePlus, China is lowing tariffs on more than 850 products from the U.S., Sarepta Therapeutics got a massive investment from Roche, and DraftKings is going public.
Read MoreGoldman Sachs says all three Strong Buy stocks could see double-digit upside next year.
Read MoreBuy Target $2.30 or better Sell Target – TradersPro Sell Signal Fortress Biotech, Inc. develops and commercializes pharmaceutical and biotechnology products. It markets dermatology products, such as Targadox for acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; Ala-Scalp and Triderm, which are used […]
Read MorePlus, we’re fast approaching the U.S. deadline to impose more tariffs on Chinese goods, House Judiciary Chairman Jerry Nadler said his committee will bring articles of impeachment against Trump this week, and Morgan Stanley says this stock is set to rocket higher.
Read MoreBuy Target – $5.57 or better Sell Signal – TradersPro Sell Signal Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics based on safely metabolized and rationally targeted (SMART) linker drug discovery platform in the United States. The company’s lead product candidate is Edasalonexent, an oral small molecule […]
Read MorePlus, it’s merger Monday, Uber lost its license to operate in London, and Tesla has 200,000 preorders for its Cybertruck.
Read MoreTrade Setup Buy Target – $5.75 or better Sell Target – TradersPro Sell Signal Avadel Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, France, and Ireland. The company primarily develops FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) […]
Read More